Work

Macroplastique® for stress urinary incontinence lights up as a PET-avid urethral lesion: A case report

Year: 2024

Type: article

Abstract: Macroplastique® is a periurethral bulking agent used for the treatment of female stress urinary incontinence. It is composed of polydimethylsiloxane macroparticles suspended in a polyvinylpyrolidone carrier to allow injection. The patient in this case report had increased 18F-FDG avidity on PET scan at the site of prior Macroplastique® injection. This avidity was likely due to a local inflammatory response and did not represent an occult malignancy. Keen clinical judgement is necessary when this PET-avid area is demonstrated in women with prior bulking therapy as this is an incidental benign finding that does not require further invasive management. • Macroplastique is a urethral bulking agent used to treat stress urinary incontinence. • Increased 18F-FDG avidity has been seen at the site of prior Macroplastique injection on PET scan. • Macroplastique 18F-FDG avidity represents a benign finding that does not require further biopsy or invasive evaluation.

Source: Case Reports in Women s Health

DOI: 10.1016/j.crwh.2024.e00649

Authors: Christine Herforth, Philippe E. Zimmern

Institution: The University of Texas Southwestern Medical Center

Language: English

Topic: Pelvic floor disorders treatments

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $860